Details
Stereochemistry | ACHIRAL |
Molecular Formula | 2In.3O4S |
Molecular Weight | 517.824 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[In+3].[In+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O
InChI
InChIKey=XGCKLPDYTQRDTR-UHFFFAOYSA-H
InChI=1S/2In.3H2O4S/c;;3*1-5(2,3)4/h;;3*(H2,1,2,3,4)/q2*+3;;;/p-6
Indium sulfate (In2(SO4)3) is a grayish-white powder. It is hydroscopic and has a monoclinic crystal structure. Indium sulfate is being marketed as the newest miracle dietary supplement and is falsely advertised as a dietary aid as an enhancer of food and mineral absorption, an anti-aging supplement, a blood pressure lowering supplement. There is no scientific support for claims that indium has beneficial effects. Indium sulfate can cause the accumulation of indium in the kidney, oxidative damage, pathological changes and dysfunction in the kidney of rats.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
[Protection from experimental indium sulfate nephrosis (effect of ferrous dextran)]. | 1968 Sep |
|
The role of lysosomes in the phenomenon of concentration of aluminum and indium in the female reproductive system. An ultrastructural study. | 2017 Dec |
|
[Renal damage of indium sulfate on rats]. | 2018 May |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/30082017
32 healthy Wistar rats were randomly and equally divided into 3 dose groups (52.3 mg/kg,104.6 mg/kg, 261.4 mg/kg) and one negative control group. Indium sulfate was orally given once a day successively 5 days a week for 8 weeks
Route of Administration:
Oral
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
514CE39CG4
Created by
admin on Sat Dec 16 03:44:16 GMT 2023 , Edited by admin on Sat Dec 16 03:44:16 GMT 2023
|
PRIMARY | |||
|
236-689-1
Created by
admin on Sat Dec 16 03:44:16 GMT 2023 , Edited by admin on Sat Dec 16 03:44:16 GMT 2023
|
PRIMARY | |||
|
DBSALT002041
Created by
admin on Sat Dec 16 03:44:16 GMT 2023 , Edited by admin on Sat Dec 16 03:44:16 GMT 2023
|
PRIMARY | |||
|
84272
Created by
admin on Sat Dec 16 03:44:16 GMT 2023 , Edited by admin on Sat Dec 16 03:44:16 GMT 2023
|
PRIMARY | |||
|
INDIUM(III) SULFATE
Created by
admin on Sat Dec 16 03:44:16 GMT 2023 , Edited by admin on Sat Dec 16 03:44:16 GMT 2023
|
PRIMARY | |||
|
m6265
Created by
admin on Sat Dec 16 03:44:16 GMT 2023 , Edited by admin on Sat Dec 16 03:44:16 GMT 2023
|
PRIMARY | Merck Index | ||
|
13464-82-9
Created by
admin on Sat Dec 16 03:44:16 GMT 2023 , Edited by admin on Sat Dec 16 03:44:16 GMT 2023
|
PRIMARY | |||
|
26044
Created by
admin on Sat Dec 16 03:44:16 GMT 2023 , Edited by admin on Sat Dec 16 03:44:16 GMT 2023
|
PRIMARY | |||
|
DTXSID50890695
Created by
admin on Sat Dec 16 03:44:16 GMT 2023 , Edited by admin on Sat Dec 16 03:44:16 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD